IMPORTANT SAFETY INFORMATION about AVANDIA® (rosiglitazone
maleate), AVANDAMET® (rosiglitazone maleate/metformin hydrochloride)
and AVANDARYL® (rosiglitazone maleate and glimepiride).

Because of a potential increased risk of myocardial infarction,
AVANDIA, AVANDAMET, and AVANDARYL are available only through the
AVANDIA-Rosiglitazone Medicines Access Program.

SAFETY INFORMATION CONTINUED BELOW

For more information about the Avandia-Rosiglitazone Medicines Access Program, please tell us who you are:

Complete Prescribing Information, including Boxed WARNING and Medication Guide, for AVANDIA, AVANDAMET, and AVANDARYL.

IMPORTANT SAFETY INFORMATION about AVANDIA® (rosiglitazone maleate), AVANDAMET® (rosiglitazone maleate/metformin hydrochloride) and AVANDARYL® (rosiglitazone maleate and glimepiride).

AVANDIA, AVANDAMET and AVANDARYL may increase your risk of a heart attack (myocardial infarction). This risk may be higher in people who are also taking insulin. Because of a potential increased risk of myocardial infarction, AVANDIA, AVANDAMET, and AVANDARYL are available only through the AVANDIA-Rosiglitazone Medicines Access Program.

This is not a complete description of the risks associated with rosiglitazone. Please refer to Boxed Warnings and full Prescribing Information.

For more information about AVANDIA, please see Medication Guide and full Prescribing Information, including Boxed WARNING.

For more information about AVANDAMET, please see Medication Guide and full Prescribing Information, including Boxed WARNING.

For more information about AVANDARYL, please see Medication Guide and full Prescribing Information, including Boxed WARNING.